首页|期刊导航|Genes & Diseases|Network pharmacology reveals that Yanghe Decoction inhibits osteosarcoma progression via ROS-induced mitochondrial dysfunction and enhances cisplatin sensitivity
Genes & Diseases2026,Vol.13Issue(3):P.617-633,17.DOI:10.1016/j.gendis.2025.101862
Network pharmacology reveals that Yanghe Decoction inhibits osteosarcoma progression via ROS-induced mitochondrial dysfunction and enhances cisplatin sensitivity
摘要
关键词
Mitochondrial function/Osteosarcoma/P38/PI3K/AKT/Yanghe decoction分类
医药卫生引用本文复制引用
Yanran Huang,Dagang Tang,Runhan Zhao,Jun Zhang,Xiao Qu,Ningdao Li,Yi Ren,Xiaoji Luo..Network pharmacology reveals that Yanghe Decoction inhibits osteosarcoma progression via ROS-induced mitochondrial dysfunction and enhances cisplatin sensitivity[J].Genes & Diseases,2026,13(3):P.617-633,17.基金项目
supported by the First Affiliated Hospital of Chongqing Medical University''s"Discipline Summit Plan"(Chongqing,China)(No.cyyy-xkdfjhcgzh-202303) (Chongqing,China)
Chongqing Young and Middle-aged Medical High-end Talent Studio(China)(No.cstc2022ycjh-bgzxm0103) (China)
the Science and Technology Research Program of Chongqing Municipal Education Commission(China)(No.KJZD-M202402802) (China)
the Horizontal Scientific Research Project of the First Affiliated Hospital of Chongqing Medical and Pharmaceutical College(Chongqing Medical and Pharmaceutical College Of China)(No.2025YGZKY01). (Chongqing Medical and Pharmaceutical College Of China)